NASDAQ : BNTX

BioNTech SE — Financial statements

Healthcare · Biotechnology · Germany

Last price 87.715 USD (Oct 30, 2026, 2:19 PM EDT) · Market cap 22.03B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

BioNTech SE (BNTX) reported revenue of 2.65B EUR (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue2.65B2.87B2.75B3.82B17.31B18.98B
Cost of Revenue619.50M611.30M541.30M599.80M3.00B2.91B
Gross Profit2.03B2.26B2.21B3.22B14.32B16.07B
Selling, General & Admin715.00M624.40M599.00M557.70M541.20M327.20M
Research & Development2.07B2.10B2.25B1.78B1.54B949.20M
Other Operating Expenses1.06B796.00M642.10M-93.40M319.10M-57.70M
Operating Expenses3.85B3.53B3.50B2.25B2.40B1.22B
Operating Income-1.82B-1.27B-1.29B971.80M11.92B14.85B
Interest Expense-14.30M-14.20M-16.90M-7.50M-18.90M-27.30M
Interest & Investment Income244.80M262.60M437.60M330.90M1.50M
Currency Exchange Gain (Loss)-15.30M-97.30M100.40M-267.90M792.40M512.50M
Other Non Operating Income (Expenses)141.90M151.00M200.40M161.50M265.30M-277.80M
EBT Excluding Unusual Items-1.46B-964.60M-564.00M1.19B12.96B15.06B
Gain (Loss) on Sale of Investments9.30M3.10M26.70M
Asset Writedown-134.30M-30.50M
Legal Settlements-44.60M-73.80M-113.70M-29.40M-3.00M-9.00M
Other Unusual Items15.00M
Pretax Income-1.63B-1.05B-677.70M1.19B12.95B15.05B
Income Tax Expense56.90M85.30M-12.40M255.80M3.52B4.75B
Earnings From Continuing Operations-1.69B-1.14B-665.30M930.30M9.43B10.29B
Net Income to Company-1.14B-665.30M930.30M9.43B10.29B
Net Income-1.69B-1.14B-665.30M930.30M9.43B10.29B
Net Income to Common-1.69B-1.14B-665.30M930.30M9.43B10.29B
Shares Outstanding (Basic)247.88M241.70M240.40M240.60M243.30M244.00M
Shares Outstanding (Diluted)247.88M241.70M240.40M242.70M249.80M259.70M
EPS (Basic)-6.80-4.70-2.773.8738.7842.18
EPS (Diluted)-6.80-4.70-2.773.8337.7739.63
Free Cash Flow469.20M280.90M-78.80M5.12B13.25B762.20M
Free Cash Flow Per Share1.891.16-0.3321.1053.032.94
Gross Margin76.62%78.70%80.32%84.29%82.70%84.66%
Operating Margin-68.57%-44.14%-46.73%25.45%68.85%78.23%
Profit Margin-63.64%-39.59%-24.18%24.36%54.50%54.24%
Free Cash Flow Margin17.71%9.79%-2.86%134.10%76.53%4.02%
EBITDA-1.38B-1.12B-1.17B1.11B11.98B14.89B
EBITDA Margin-52.11%-39.17%-42.69%29.07%69.22%78.48%
D&A For EBITDA436.20M142.60M111.00M138.20M64.50M46.20M
EBIT-1.82B-1.27B-1.29B971.80M11.92B14.85B
EBIT Margin-68.57%-44.14%-46.73%25.45%68.85%78.23%
Effective Tax Rate21.57%27.17%31.60%
Revenue as Reported18.98B

Balance sheet

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents9.74B7.68B9.76B11.66B13.88B1.69B
Short-Term Investments3.72B6.07B6.08B4.89B189.40M381.60M
Cash & Short-Term Investments13.46B13.74B15.84B16.55B14.06B2.07B
Accounts Receivable174.30M932.30M1.47B2.16B7.15B12.38B
Other Receivables70.90M52.60M50.00M179.10M400.00K400.00K
Receivables245.20M984.90M1.52B2.34B7.15B12.38B
Inventory100.60M110.70M283.30M357.70M439.60M502.50M
Other Current Assets1.49B1.31B1.15B281.10M271.90M113.40M
Total Current Assets15.30B16.15B18.80B19.53B21.92B15.07B
Property, Plant & Equipment1.22B1.29B1.18B971.60M821.10M520.40M
Long-Term Investments1.85B2.45B1.21B1.18B80.20M21.30M
Goodwill373.30M367.90M380.60M362.50M61.20M57.80M
Other Intangible Assets1.42B1.61B790.40M781.70M145.40M136.80M
Long-Term Accounts Receivable2.00M9.80M
Long-Term Deferred Tax Assets15.70M13.50M81.70M81.30M229.60M
Other Long-Term Assets167.80M107.30M67.20M105.80M19.60M22.20M
Total Assets20.34B21.99B22.53B23.01B23.28B15.83B
Accounts Payable646.70M534.90M426.70M354.00M204.10M160.00M
Current Portion of Long-Term Debt10.80M7.20M102.00M
Current Portion of Leases46.40M45.00M39.50M28.10M36.00M27.90M
Current Income Taxes Payable21.20M65.60M4.50M525.50M595.90M1.57B
Current Unearned Revenue742.50M754.90M294.90M353.30M77.10M186.10M
Other Current Liabilities481.60M734.70M1.76B809.60M2.04B1.44B
Total Current Liabilities1.95B2.14B2.52B2.07B2.95B3.48B
Long-Term Debt102.10M29.90M2.40M2.10M17.90M
Long-Term Leases156.80M185.30M214.70M188.60M174.10M153.70M
Long-Term Unearned Revenue87.60M88.00M183.00M398.50M48.40M9.00M
Long-Term Deferred Tax Liabilities33.30M84.30M42.40M39.70M6.20M66.70M
Other Long-Term Liabilities256.10M234.60M155.30M60.70M42.10M208.20M
Total Liabilities2.59B2.76B3.12B2.76B3.22B3.94B
Common Stock259.00M259.00M248.60M248.60M248.60M246.30M
Retained Earnings16.61B17.96B19.10B19.76B18.83B9.88B
Treasury Stock-7.80M-7.70M-8.60M-10.80M-5.30M-3.80M
Comprehensive Income & Other897.10M1.01B73.10M244.80M979.30M1.77B
Total Common Equity17.76B19.22B19.41B20.25B20.06B11.89B
Shareholders' Equity17.76B19.22B19.41B20.25B20.06B11.89B
Total Liabilities & Equity20.34B21.99B22.53B23.01B23.28B15.83B
Total Debt316.10M267.40M254.20M219.10M212.20M301.50M
Net Cash (Debt)13.15B13.47B15.59B16.33B13.85B1.77B
Net Cash Per Share53.0455.7464.8567.2855.456.83
Filing Date Shares Outstanding251.20M239.97M239.97M237.73M240.99M242.52M
Total Common Shares Outstanding251.20M251.33M239.97M237.73M243.22M242.52M
Working Capital13.35B14.00B16.28B17.46B18.97B11.59B
Book Value Per Share70.6976.4980.8985.1682.4649.04
Tangible Book Value15.96B17.25B18.24B19.10B19.85B11.70B
Tangible Book Value Per Share63.5468.6476.0180.3581.6148.24
Land586.40M369.40M235.40M217.00M104.10M
Machinery491.50M427.70M344.10M273.00M198.30M
Construction In Progress478.50M460.60M389.50M235.50M94.30M

Cash flow statement

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-1.69B-1.14B-665.30M930.30M9.43B10.29B
Depreciation & Amortization478.90M185.30M156.60M183.40M123.30M75.20M
Loss (Gain) From Sale of Assets-3.10M-2.50M-300.00K3.80M600.00K4.60M
Asset Writedown & Restructuring Costs197.50M197.50M141.40M
Loss (Gain) From Sale of Investments-10.40M-10.40M4.60M175.50M-241.00M57.30M
Stock-Based Compensation70.40M80.90M-53.60M-714.80M56.80M80.50M
Other Operating Activities527.50M603.50M-596.30M-781.60M-315.20M1.11B
Change in Accounts Receivable1.77B1.08B387.70M5.37B4.37B-11.81B
Change in Inventory131.50M177.90M74.50M81.90M62.90M-438.40M
Change in Accounts Payable-798.60M-723.80M758.40M118.90M85.70M1.52B
Operating Cash Flow679.70M456.00M207.70M5.37B13.58B889.70M
Capital Expenditures-210.50M-175.10M-286.50M-250.10M-329.20M-127.50M
Sale of Property, Plant & Equipment8.50M4.50M1.20M600.00K3.40M
Cash Acquisitions264.80M186.30M-336.90M-20.80M
Sale (Purchase) of Intangibles-24.50M-573.90M-165.80M-455.40M-34.10M-26.50M
Investment in Securities-1.14B-1.91B-1.63B-5.91B327.40M-394.70M
Investing Cash Flow-1.10B-2.47B-2.08B-6.95B-35.30M-566.10M
Long-Term Debt Issued6.70M300.00K800.00K
Long-Term Debt Repaid-57.60M-45.90M-40.40M-59.90M-66.70M
Lease Payments-43.90M-39.60M-43.60M-40.30M-41.10M-14.10M
Net Debt Issued (Repaid)23.30M-50.90M-45.90M-40.10M-59.10M-66.70M
Issuance of Common Stock110.50M163.60M
Repurchase of Common Stock-129.20M-738.50M-986.40M
Other Financing Activities-2.00M-2.00M-2.70M
Financing Cash Flow-107.90M-52.90M-45.90M-778.60M-1.42B94.20M
Foreign Exchange Rate Adjustments-26.80M-27.00M14.80M-14.50M60.10M64.70M
Miscellaneous Cash Flow Adjustments26.90M5.90M2.80M164.80M-500.00K
Net Cash Flow-528.50M-2.09B-1.90B-2.21B12.18B482.50M
Free Cash Flow469.20M280.90M-78.80M5.12B13.25B762.20M
Free Cash Flow Margin17.71%9.79%-2.86%134.10%76.53%4.02%
Free Cash Flow Per Share1.891.16-0.3321.1053.032.94
Levered Free Cash Flow-249.56M-1.10B-548.20M4.14B12.01B-646.60M
Unlevered Free Cash Flow-240.62M-1.09B-537.64M4.14B12.02B-629.54M
Free Cash Flow After Leases425.30M241.30M-122.40M5.08B13.21B748.10M
Cash Interest Paid10.80M11.00M13.50M5.40M21.50M12.20M
Cash Income Tax Paid26.80M-3.80M389.20M482.90M4.22B3.46B
Change in Working Capital1.11B537.80M1.22B5.57B4.52B-10.73B

Ratios

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization22.15B22.89B27.32B25.09B36.51B62.26B
Enterprise Value7.13B6.32B8.96B8.63B23.61B59.82B
Last Close Price88.1795.20113.95105.54150.22255.33
PE Ratio24.403.625.32
Forward PE100.62100.6267.818.278.07
PS Ratio7.326.799.595.941.972.88
PB Ratio1.091.011.361.121.704.60
P/TBV Ratio1.211.131.451.191.724.68
P/FCF Ratio42.2169.414.432.5871.83
P/OCF Ratio29.1442.76127.044.232.5261.54
PEG Ratio0.010.010.010.010.02
EV/Sales Ratio2.351.883.152.041.282.77
EV/EBITDA Ratio7.041.843.53
EV/EBIT Ratio8.041.853.54
EV/FCF Ratio13.5819.161.521.6769.01
Debt / Equity Ratio0.020.010.010.010.010.03
Debt / EBITDA Ratio0.190.020.02
Debt / FCF Ratio0.670.950.040.020.40
Net Debt / Equity Ratio-0.74-0.70-0.80-0.81-0.69-0.15
Net Debt / EBITDA Ratio9.5211.9913.27-14.71-1.16-0.12
Net Debt / FCF Ratio-28.02-47.96197.84-3.19-1.05-2.33
Asset Turnover0.130.130.120.170.892.09
Inventory Turnover3.743.101.691.506.3610.28
Quick Ratio7.036.876.889.127.194.15
Current Ratio7.857.547.459.437.434.33
Return on Equity (ROE)-9.30%-5.88%-3.36%4.62%59.06%155.18%
Return on Assets (ROA)-5.41%-3.56%-3.53%2.62%38.09%102.25%
Return on Invested Capital (ROIC)-36.69%-26.47%-33.23%15.06%106.34%195.58%
Return on Capital Employed (ROCE)-9.90%-6.40%-6.40%4.60%58.60%120.20%
Earnings Yield-8.82%-5.83%-2.52%4.10%27.62%18.80%
FCF Yield2.37%1.44%-0.30%22.56%38.78%1.39%
Buyback Yield / Dilution-3.00%-0.54%0.95%2.84%3.81%-4.51%